Congratualtions to Medicilon’s partner Bio-Thera

저자：medicilon   업로드：2020-06-04  조회수：

Congratualtions to Medicilon’s partner, Bio-Thera, on obtaining NMPA’s approval of clinical trials of BAT1308.

On May 27th, 2020, Bio-Thera Solutions, Ltd, annouced the approval of clinical trials on BAT 1308, an anti PD-1 monoclonal antibody. Medicilon participated in BAT 1308’s preclinical study by conducting the In Vivo PK test and safety evaluation tests under GLP.

이전：최고 임시

다음에：Congratulations on the successful listing of Kintor Pharma